Karer, Matthias
Rager-Resch, Marlene
Haider, Teresa
Petroczi, Karin
Gludovacz, Elisabeth
Borth, Nicole
Jilma, Bernd
Boehm, Thomas http://orcid.org/0000-0002-8294-0797
Funding for this research was provided by:
Austrian Science Fund (SFB54-04, T1135)
Medical University of Vienna
Article History
Received: 6 December 2021
Revised: 21 February 2022
Accepted: 4 March 2022
First Online: 18 March 2022
Declarations
:
: TB, BJ, EG and NB are named inventors of a patent describing the heparin-binding motif rhDAO mutants (patent pending WO2020169577A1). The other authors declare that they have no conflicts of interest.